Description
CJC-1295 without DAC (also known as Modified GRF 1-29) is a tetrasubstituted analog of Growth Hormone-Releasing Hormone (GHRH). It has been rigorously researched to prove to stimulate the release of endogenous growth hormone from pituitary somatotrophs in a pulsatile manner, mimicking the body’s natural circadian rhythm. Unlike its counterpart with DAC (Drug Affinity Complex), this compound possesses a shorter half-life in laboratory models, allowing researchers to study acute GHRH signaling without creating the “GH bleed” associated with continuous receptor stimulation. It is a primary agent for investigating sleep cycle regulation and physiological growth signalling.
Ingredients
-
Active Agent: Modified GRF 1-29 (Tetrasubstituted GHRH 1-29)
-
Format: Sterile Lyophilized Powder (requires reconstitution)
-
Concentration: 5mg per vial
-
Purity: ≥99% (HPLC Verified)
-
Sequence: Tyr-D-Ala-Asp-Ala-Ile-Phe-Thr-Gln-Ser-Tyr-Arg-Lys-Val-Leu-Ala-Gln-Leu-Ser-Ala-Arg-Lys-Leu-Leu-Gln-Asp-Ile-Leu-Ser-Arg-NH2
